1. Volume 151, Issue 1, Pages 97-109.e4 (July 2016)
Cancer Recurrence Following Immune-Suppressive Therapies in Patients With Immune- Mediated Diseases: A Systematic Review and Meta-analysis 
Edward Shelton, David Laharie, Frank I. Scott, Ronac Mamtani, James D. Lewis, Jean-Frederic Colombel, Ashwin N. Ananthakrishnan 
Gastroenterology 
Volume 151, Issue 1, Pages e4 (July 2016)
DOI: /j.gastro
Copyright © 2016 AGA Institute Terms and Conditions

2. Figure 1 Flowchart of the literature search.
Gastroenterology  , e4DOI: ( /j.gastro )
Copyright © 2016 AGA Institute Terms and Conditions

3. Figure 2
Forest plot of risk of recurrence of cancer or development of new primary by type of immunosuppression in individuals with a prior history of cancer. NMSC, nonmelanoma skin cancer.
Gastroenterology  , e4DOI: ( /j.gastro )
Copyright © 2016 AGA Institute Terms and Conditions

4. Figure 3
Forest plot of risk of new primary cancer by type of immunosuppression in individuals with a prior history of cancer. NMSC, nonmelanoma skin cancer.
Gastroenterology  , e4DOI: ( /j.gastro )
Copyright © 2016 AGA Institute Terms and Conditions

5. Figure 4
Forest plot of risk of recurrence of prior cancer by type of immunosuppression in individuals with a prior history of cancer.
Gastroenterology  , e4DOI: ( /j.gastro )
Copyright © 2016 AGA Institute Terms and Conditions

6. Figure 5
Incident rate differences between no immunosuppression, conventional immunomodulator, and anti-TNF therapy. (A) Conventional IMM vs anti-TNF therapy. (B) Conventional IMM vs no IS. (C) Anti-TNF vs no IS. NMSC, nonmelanoma skin cancer.
Gastroenterology  , e4DOI: ( /j.gastro )
Copyright © 2016 AGA Institute Terms and Conditions

7. Supplementary Figure 1
Risk of recurrence of cancer or development of a new primary by type of immunosuppression in individuals with inflammatory bowel disease and a prior history of cancer. NMSC, nonmelanoma skin cancer.
Gastroenterology  , e4DOI: ( /j.gastro )
Copyright © 2016 AGA Institute Terms and Conditions

8. Supplementary Figure 2
Risk of recurrence of cancer or development of a new primary by type of immunosuppression in individuals with rheumatoid arthritis and a prior history of cancer. NMSC, nonmelanoma skin cancer.
Gastroenterology  , e4DOI: ( /j.gastro )
Copyright © 2016 AGA Institute Terms and Conditions

9. Supplementary Figure 3
Egger plot for assessment of publication bias. SND, standard error.
Gastroenterology  , e4DOI: ( /j.gastro )
Copyright © 2016 AGA Institute Terms and Conditions